Nisa Investment Advisors, LLC Incyte Corp Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 30,256 shares of INCY stock, worth $2.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

30,256

Previous 31,858 5.03%

Holding current value

$2.11 Million

Previous $1.93 Million 3.52%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$57.33 - $68.61 $91,842 - $109,913	-1,602 Reduced 5.03%	30,256 $2 Million
Q2 2024 Jul 19, 2024	SELL	$51.18 - $63.75 $2.15 Million - $2.68 Million	-41,977 Reduced 56.85%	31,858 $1.93 Million
Q1 2024 May 01, 2024	BUY	$56.55 - $66.59 $1.91 Million - $2.25 Million	33,835 Added 84.59%	73,835 $4.21 Million
Q4 2023 Jan 25, 2024	BUY	$52.16 - $64.19 $203,058 - $249,891	3,893 Added 10.78%	40,000 $2.51 Million
Q3 2023 Nov 02, 2023	SELL	$57.77 - $65.93 $456,671 - $521,176	-7,905 Reduced 17.96%	36,107 $2.09 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $1.77 Million - $2.2 Million	-29,083 Reduced 39.79%	44,012 $2.74 Million
Q1 2023 May 02, 2023	BUY	$70.23 - $86.01 $1.01 Million - $1.24 Million	14,365 Added 24.46%	73,095 $5.28 Million
Q4 2022 Feb 02, 2023	SELL	$67.18 - $84.11 $141,816 - $177,556	-2,111 Reduced 3.47%	58,730 $4.72 Million
Q3 2022 Nov 07, 2022	SELL	$66.18 - $82.86 $1 Million - $1.25 Million	-15,131 Reduced 19.92%	60,841 $4.06 Million
Q2 2022 Aug 03, 2022	SELL	$66.18 - $83.18 $62,540 - $78,605	-945 Reduced 1.23%	75,972 $5.77 Million
Q1 2022 Apr 29, 2022	SELL	$66.02 - $79.71 $348,057 - $420,231	-5,272 Reduced 6.41%	76,917 $6.11 Million
Q4 2021 Feb 03, 2022	BUY	$63.34 - $74.11 $167,344 - $195,798	2,642 Added 3.32%	82,189 $6.11 Million
Q3 2021 Oct 18, 2021	BUY	$68.67 - $84.02 $60,704 - $74,273	884 Added 1.12%	79,547 $5.47 Million
Q2 2021 Aug 06, 2021	BUY	$79.87 - $87.53 $1.29 Million - $1.42 Million	16,170 Added 25.87%	78,663 $6.62 Million
Q1 2021 Apr 26, 2021	BUY	$76.02 - $100.5 $53,442 - $70,651	703 Added 1.14%	62,493 $5.08 Million
Q4 2020 Jan 25, 2021	SELL	$80.74 - $97.7 $827,988 - $1 Million	-10,255 Reduced 14.23%	61,790 $5.37 Million
Q3 2020 Oct 20, 2020	SELL	$85.07 - $109.69 $436,238 - $562,490	-5,128 Reduced 6.64%	72,045 $6.47 Million
Q2 2020 Jul 27, 2020	BUY	$74.18 - $108.93 $786,827 - $1.16 Million	10,607 Added 15.93%	77,173 $8.02 Million
Q1 2020 Apr 17, 2020	BUY	$63.18 - $85.97 $1.67 Million - $2.27 Million	26,388 Added 65.68%	66,566 $4.88 Million
Q4 2019 Jan 17, 2020	BUY	$73.04 - $95.72 $361,182 - $473,335	4,945 Added 14.04%	40,178 $3.51 Million
Q3 2019 Oct 17, 2019	SELL	$72.82 - $86.52 $65,683 - $78,041	-902 Reduced 2.5%	35,233 $2.62 Million
Q2 2019 Jul 12, 2019	BUY	$73.52 - $88.7 $207,326 - $250,134	2,820 Added 8.46%	36,135 $3.07 Million
Q1 2019 Apr 17, 2019	BUY	$63.56 - $88.17 $684,859 - $950,031	10,775 Added 47.8%	33,315 $2.87 Million
Q4 2018 Jan 17, 2019	SELL	$58.5 - $69.94 $868,257 - $1.04 Million	-14,842 Reduced 39.7%	22,540 $1.43 Million
Q3 2018 Oct 16, 2018	BUY	$61.75 - $74.23 $992,322 - $1.19 Million	16,070 Added 75.4%	37,382 $2.58 Million
Q2 2018 Jul 19, 2018	SELL	$60.85 - $83.98 $1.37 Million - $1.89 Million	-22,548 Reduced 51.41%	21,312 $1.43 Million
Q1 2018 Apr 10, 2018	BUY	$83.06 - $100.98 $1.75 Million - $2.13 Million	21,100 Added 92.71%	43,860 $3.7 Million
Q4 2017 Jan 12, 2018	SELL	$93.56 - $116.6 $1.31 Million - $1.63 Million	-13,966 Reduced 38.03%	22,760 $2.16 Million
Q3 2017 Oct 13, 2017	BUY	$109.15 - $138.27 $4.01 Million - $5.08 Million	36,726	36,726 $4.29 Million

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Incyte Corp Transaction History